Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0641
D

Inaccurate MDS Assessment for Antipsychotic Medication Use

Bellefonte, Pennsylvania Survey Completed on 08-15-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure complete and accurate Minimum Data Set (MDS) assessments for one resident. Clinical record review showed that the resident had a physician's order for Nuplazid, an antipsychotic medication, which was prescribed to be taken orally at bedtime. However, quarterly MDS assessments completed on two separate dates did not indicate that the resident was receiving an antipsychotic medication. This discrepancy was confirmed through interviews with the Director of Nursing and the Nursing Home Administrator, who acknowledged that the MDS assessments were not accurately coded to reflect the resident's medication regimen. The resident involved had a documented order for Nuplazid to treat hallucinations associated with Parkinson's disease, but this was not reflected in the required MDS documentation, resulting in an inaccurate assessment of the resident's care needs.

An unhandled error has occurred. Reload 🗙